021-51111890
购物车（）
sales@molnova.cn
Inotuzumab
CAS No. 1660159-36-3
Inotuzumab ( —— )
产品货号. M36722 CAS No. 1660159-36-3
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) 是人源化的 IgG4，κ 抗体靶向人 CD22。Inotuzumab 与毒素奥加米星 (ozogamicin) 相连接可作为抗体-活性分子偶联物 (ADC)。Inotuzumab 可于急性淋巴细胞白血病和非霍奇金淋巴瘤的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥5216 | 有现货 |
|
| 10MG | ￥7106 | 有现货 |
|
| 25MG | ￥10137 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Inotuzumab
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) 是人源化的 IgG4，κ 抗体靶向人 CD22。Inotuzumab 与毒素奥加米星 (ozogamicin) 相连接可作为抗体-活性分子偶联物 (ADC)。Inotuzumab 可于急性淋巴细胞白血病和非霍奇金淋巴瘤的研究。
-
产品描述Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4, κ antibody that targets human CD22. Inotuzumab can be linked to a toxic agent ozogamicin as an antibody-drug conjugate (ADC). Inotuzumab can be used for the research of acute lymphoblastic leukemia and non-Hodgkin lymphoma.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体ADC Antibody
-
研究领域——
-
适应症——
化学信息
-
CAS Number1660159-36-3
-
分子量Approximately 146.48 kDa.
-
分子式——
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Aujla A, et al. Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma. Biomark Res. 2019 Apr 11;7:9.?
产品手册
关联产品
-
Dihydromollugin
Dihydromollugin is a naphthol ester found in Rubia cordifolia that may have anti-tumour, virus-inhibiting and other activities.
-
Nur77 modulator 1
Nur77 调节剂 1 是一种良好的 Nur77 结合剂 (KD = 3.58 μM)。 Nur77 调节剂 1 上调 Nur77 表达，介导 Nur77 的亚细胞定位，诱导 Nur77 依赖性 ER 应激和自噬，并导致细胞凋亡。抗肝癌活性。
-
Pendulone
Pendulone could be a valuable chemopreventive agent, it shows strong inhibition on the effect of the cell cycle induced by TPA and shows potent anti-tumor-promoting activity for an in vivo two-stage carcinogenesis test.
